Free Trial

Chugai Pharmaceutical (CHGCY) Earnings Date, Estimates & Call Transcripts

Chugai Pharmaceutical logo
$29.81 +0.83 (+2.86%)
As of 05/2/2025 03:59 PM Eastern

Chugai Pharmaceutical Earnings Summary

Latest Q1 2025
Earnings Date
Apr. 24Estimated
Actual EPS
(Apr. 24)
$0.19 Beat By $0.19
Actual Revenue
(Apr. 24)
$1.89B

Chugai Pharmaceutical posted Q1 2025 earnings on April 24, 2025, reporting an EPS of $0.19. Quarterly revenue was reported to be $1.89 billion. With a trailing EPS of $0.81 and a P/E Ratio of 38.71, Chugai Pharmaceutical's earnings are expected to grow 5.41% next year, from $0.74 to $0.78 per share.

Q1 2025 Earnings Resources

Get Chugai Pharmaceutical Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Chugai Pharmaceutical and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

CHGCY Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CHGCY Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Chugai Pharmaceutical Analyst EPS Estimates

Current Year EPS Consensus Estimate
$0.74 EPS
Next Year EPS Consensus Estimate
$0.78 EPS

Chugai Pharmaceutical Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
4/24/2025Q1 2025-$0.19+$0.19$0.19-$1.89B
1/30/2025Q4 2024-$0.18+$0.18$0.18--
10/25/2024--$0.22+$0.22$0.22-$2.12B
7/25/2024Q2 2024-$0.22+$0.22$0.22-$2.03B
4/24/2024Q1 2024-$0.15+$0.15$0.15-$1.60B
2/1/2024Q4 2023$0.18$0.19+$0.01$0.19-$1.85B
10/24/2023Q3 2023-$0.16+$0.16$0.16-$1.78B
7/27/2023Q2 2023-$0.18+$0.18$0.18-$1.95B

Chugai Pharmaceutical Earnings - Frequently Asked Questions

Chugai Pharmaceutical (OTCMKTS:CHGCY) last announced its quarterly earning data on Thursday, April 24, 2025. Learn more on CHGCY's earnings history.

Chugai Pharmaceutical (OTCMKTS:CHGCY) has a recorded annual revenue of $7.74 billion.

Chugai Pharmaceutical (OTCMKTS:CHGCY) has a recorded net income of $2.56 billion. CHGCY has generated $0.81 earnings per share over the last four quarters.

Chugai Pharmaceutical (OTCMKTS:CHGCY) has a trailing price-to-earnings ratio of 38.71 and a forward price-to-earnings ratio of 40.28.

Chugai Pharmaceutical's earnings are expected to grow from $0.74 per share to $0.78 per share in the next year, which is a 5.41% increase.

More Earnings Resources from MarketBeat



This page (OTCMKTS:CHGCY) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners